reports
- Jonathan Moreland
WAT WATERS CORPORATION
VNO VORNADO REALTY TRUST
TGL. TECNOGLASS INC.
SCM STELLUS CAPITAL INVESTMENT CORP
ROCK GIBRALTAR INDUSTRIES INC.
POOL POOL CORPORATION
OSUR ORASURE TECHNOLOGIES INC.
NSP INSPERITY INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
NFBK NORTHFIELD BANCORP INC.
MTN VAIL RESORTS INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
CRM SALESFORCE.COM INC.
BBSI BARRETT BUSINESS SERVICES INC.
WD WALKER & DUNLOP INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
PLBC PLUMAS BANCORP
BWFG BANKWELL FINANCIAL GROUP
SVRA SAVARA
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
ULBI ULTRALIFE
SONO SONOS
EML THE EASTERN COMPANY
STIM STIMSONITE CORP
BLDR BUILDERS FIRSTSOURCE
AEYE INC.
PHR AUDIOEYE INC
AHCO PHREESIA
AVO ADAPTHEALTH
AMR MISSION PRODUCE
TRIN ALPHA METALLURGICAL RESOURCES INC
AIRS TRINITY CAPITAL INC
EXFY AIRSCULPT TECHNOLOGIES INC
SBSW EXPENSIFY INC
VANI SIBANYE-STILLWATER LTD
GRNT VIVANI MEDICAL INC
NBBK GRANITE RIDGE RESOURCES INC
SDHC NB BANCORP INC.
MXF SMITH DOUGLAS HOMES CORP
SNES THE MEXICO FUND
GF INC.
AFCG SENESTECH INC.
SI THE NEW GERMANY FUND
SENS INC.
AFC GAMMA
INC.
SHOULDER INNOVATIONS INC
SENSEONICS HOLDINGS INC.
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-...
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01 STAFFORD, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the initiation of new clinical sites in the US. The Phase III clinical trial has recently been activated at City of Hope, one of the largest and most advanced cancer research and treatment...
- Jonathan Moreland
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting STAFFORD, Texas, March 18, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided an update on the upcoming AACR Meeting 2026. Two abstracts and two posters were accepted for presentation. The titles and authors of the abstracts are as follows: Abstract Number: CT138 - Poster Se...
- Jonathan Moreland
SCM STELLUS CAPITAL INVESTMENT CORP
POOL POOL CORPORATION
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
SONO SONOS
TCPC BLACKROCK TCP CAPITAL CORP.
EML THE EASTERN COMPANY
AEYE AUDIOEYE INC
PTON PELOTON INTERACTIVE
CMTV INC.
AVO COMMUNITY BANCORP INC. VT
FOA MISSION PRODUCE
TRIN FINANCE OF AMERICA COMPANIES INC.
WEST TRINITY CAPITAL INC
SDHC WESTROCK COFFEE COMPANY LLC
SNES SMITH DOUGLAS HOMES CORP
SI SENESTECH INC.
MOVE SHOULDER INNOVATIONS INC
MOVANO INC.
Greenwich LifeSciences Provides Update Showing Continued Reduction in ...
Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01 STAFFORD, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided a preliminary update showing a continued reduction in the recurrence rate in the fully enrolled, 250 patient, open label non-HLA-A*02 arm of FLAMINGO-01. 6 Month...
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 ...
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01 STAFFORD, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following update on the use of commercially manufactured GP2 in FLAMINGO-01. All US Sites Treating Patients with Commercially Manufactured GP2 The Company previously announced that the first thr...
Mission Produce® Announces Fiscal 2026 First Quarter Financial Results
Mission Produce® Announces Fiscal 2026 First Quarter Financial Results Pending acquisition of Calavo Growers progressing; expected to close in the fiscal third quarter OXNARD, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados, today reported its financial results for the fiscal first quarter ended January 31, 2026. Fiscal First Quarter 2026 Financial Overview: Total revenue of $278.6 million and achieved volume growth of 14% compared to the same perio...
Greenwich LifeSciences Provides Update on Increased Patient Screen Rat...
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 STAFFORD, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided an update on the increased patient screen rate in FLAMINGO-01. FLAMINGO-01 Annual Patient Screen Rate Increases to Over 800 Patients per Year Over the past 6 months, the Comp...
Simon Property Group Inc: 1 director
A director at Simon Property Group Inc sold 10,000 shares at 200.880USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Mission Produce® to Release Fiscal First Quarter 2026 Financial Result...
Mission Produce® to Release Fiscal First Quarter 2026 Financial Results on Thursday, March 12, 2026 OXNARD, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, and distributing fresh Hass avocados, today announced it will release its financial results for the fiscal first quarter ended January 31, 2026 after the market closes on Thursday, March 12, 2026. The Company will host a conference call and webcast to discuss its financial results at 5:00 PM Eastern Time on the same day. Conference Call D...
Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR A...
Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 STAFFORD, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that two abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026, including two corresponding poster...
- Jonathan Moreland
SCSC SCANSOURCE INC.
PSEC PROSPECT CAPITAL CORPORATION
MSCI MSCI INC. CLASS A
MOH MOLINA HEALTHCARE INC.
MMS MAXIMUS INC.
KVHI KVH INDUSTRIES INC.
HTGC HERCULES CAPITAL INC.
FAF FIRST AMERICAN FINANCIAL CORPORATION
BMI BADGER METER INC.
ARE ALEXANDRIA REAL ESTATE EQUITIES INC.
PRU PRUDENTIAL FINANCIAL INC.
ASA ASA
WY WEYERHAEUSER COMPANY
MDU MDU RESOURCES GROUP INC
MEDP MEDPACE HOLDINGS INC.
SAH SONIC AUTOMOTIVE INC. CLASS A
TSI TCW STRATEGIC INCOME FUND INC.
PLBC PLUMAS BANCORP
GRF EAGLE CAPITAL GROWTH FUND INC
CNDT CONDUENT INC.
MSFT MICROSOFT CORPORATION
SSTI SHOTSPOTTER
ZIVO ZIVO BIOSCIENCE
KKR INC.
BOTJ KKR & CO. INC.
AXR BANK OF THE JAMES FINANCIAL GROUP INC.
TENB AMREP
AVTR TENABLE HOLDINGS
CMTV AVANTOR
VERX INC.
BIGC COMMUNITY BANCORP INC. VT
SLQT VERTEX
DLHC INC.
AFRM BIGCOMMERCE HOLDINGS
FLYW SELECTQUOTE
CHRW INC.
TBBK DALEIGH HOLDINGS CORP
QDEL AFFIRM HOLDINGS
IE FLYWIRE CORP
CHUC C.H. ROBINSON WORLDWIDE
RXO_w INC.
GTE THE BANCORP
CNVS INC.
COCH QUIDEL CORP
ASST IVANHOE ELECTRIC INC
SPGI CHARLIES HLDGS INC
EKSO RXO INC
NDAQ GRAN TIERRA ENERGY INC.
LNZA CINEVERSE CORP
ANZU SPECIAL ACQUISITION CORP I
ASSET ENTITIES INC.
MCGRAW HILL FINANCIAL INC
EKSO BIONICS HOLDINGS INC.
THE NASDAQ OMX GROUP
INC.
LANZATECH GLOBAL INC
Asa Gold & Precious Metals Ltd: 1 director
A director at Asa Gold & Precious Metals Ltd sold 13,355 shares at 70.600USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
- Jonathan Moreland
CINF CINCINNATI FINANCIAL CORPORATION
ASA ASA
MDU MDU RESOURCES GROUP INC
MEDP MEDPACE HOLDINGS INC.
NWPP NEW PEOPLES BANKSHARES INC.
ZIVO ZIVO BIOSCIENCE
SONO INC.
JYNT SONOS
RXO_w THE JOINT
VANI RXO INC
GTE VIVANI MEDICAL INC
CNVS GRAN TIERRA ENERGY INC.
COCH CINEVERSE CORP
MXF ANZU SPECIAL ACQUISITION CORP I
GF THE MEXICO FUND
EKSO INC.
THE NEW GERMANY FUND
INC.
EKSO BIONICS HOLDINGS INC.
- Jonathan Moreland
VRNS VARONIS SYSTEMS INC.
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
TWI TITAN INTERNATIONAL INC.
SLP SIMULATIONS PLUS
SCSC SCANSOURCE INC.
PSEC PROSPECT CAPITAL CORPORATION
PAYX PAYCHEX INC.
NG. NOVAGOLD RESOURCES INC.
MOH MOLINA HEALTHCARE INC.
MMS MAXIMUS INC.
LMAT LEMAITRE VASCULAR INC.
KVHI KVH INDUSTRIES INC.
GKOS GLAUKOS CORP
CINF CINCINNATI FINANCIAL CORPORATION
BMI BADGER METER INC.
ARE ALEXANDRIA REAL ESTATE EQUITIES INC.
ARCC ARES CAPITAL CORPORATION
ASA ASA
PRU PRUDENTIAL PLC
TSI TCW STRATEGIC INCOME FUND INC.
PLBC PLUMAS BANCORP
GRF EAGLE CAPITAL GROWTH FUND INC
LW LAMB WESTON HOLDINGS INC.
HWKN HAWKINS INC.
WDFC WD-40 COMPANY
PW POWER REIT
ABT ABBOTT LABORATORIES
KKR KKR & CO. INC.
AXR AMREP
SONO SONOS
TENB TENABLE HOLDINGS
AVTR AVANTOR
CMTV INC.
AON COMMUNITY BANCORP INC. VT
BSTZ AON PLC CLASS A
AFRM BLACKROCK SCIENCE AND TECHNOLOGY TRUST II
INTA AFFIRM HOLDINGS
TMC INTAPP INC
CHRW TMC THE METALS CO INC
TBBK C.H. ROBINSON WORLDWIDE
FRST INC.
QDEL THE BANCORP
CHUC INC.
PMN PRIMIS FINANCIAL CORP
HYMC QUIDEL CORP
CING CHARLIES HLDGS INC
SPGI PROMIS NEUROSCIENCES INC.
HYCROFT MINING HOLDING CORPORATION
CINGULATE INC
MCGRAW HILL FINANCIAL INC
- Jonathan Moreland
KVHI KVH INDUSTRIES INC.
ASA ASA
PRU PRUDENTIAL PLC
TSI TCW STRATEGIC INCOME FUND INC.
GRF EAGLE CAPITAL GROWTH FUND INC
ZIVO ZIVO BIOSCIENCE
AXR INC.
AVTR AMREP
AON AVANTOR
BSTZ INC.
TBBK AON PLC CLASS A
NPWR BLACKROCK SCIENCE AND TECHNOLOGY TRUST II
FIG THE BANCORP
SPGI INC.
NET POWER INC
FIGMA INC.
MCGRAW HILL FINANCIAL INC
- Jonathan Moreland
- Jonathan Moreland
- Jonathan Moreland
MNRO MONRO INC
HUN HUNTSMAN CORPORATION
ASA ASA
ENPH ENPHASE ENERGY INC.
TYIA JOHNSON CONTROLS INTERNATIONAL PLC
HYT BLACKROCK CORPORATE HIGH YIELD FUND VI
CVCO CAVCO INDUSTRIES INC.
ETON ETON PHARMACEUTICALS
LUMN LUMEN TECHNOLOGIES INC.
ZIP ZIPRECRUITER
TMC INC.
TBBK TMC THE METALS CO INC
LSF THE BANCORP
PMN INC.
GF LAIRD SUPERFOOD INC
PROMIS NEUROSCIENCES INC.
THE NEW GERMANY FUND
INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.